IWMPD
NKTR icon

Integrated Wealth Management (Palm Desert)’s Nektar Therapeutics NKTR Stock Holding History

Integrated Wealth Management (Palm Desert)’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-33
Closed -$9K – 748
2016
Q3 		$9K Buy
+33
New +$8.5K ﹤0.01% 791

Other funds holding NKTR

O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Integrated Wealth Management (Palm Desert)'s NKTR Position: Q4 2016 in Review

Integrated Wealth Management (Palm Desert) sold out of Nektar Therapeutics (NKTR) in Q4 2016, closing a stake of 33 shares — an estimated $9K sold.

Integrated Wealth Management (Palm Desert) first reported a position in NKTR in Q3 2016 and held it in 1 quarter. The position peaked at $9K in Q3 2016. 199 funds tracked by Wall St. Rank hold NKTR as of Q4 2016.

  • Integrated Wealth Management (Palm Desert) reported no remaining Nektar Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Integrated Wealth Management (Palm Desert) sold 33 Nektar Therapeutics shares in Q4 2016, an estimated $9K.
  • Integrated Wealth Management (Palm Desert) first reported a position in Nektar Therapeutics in Q3 2016 and held it in 1 quarter.
  • Integrated Wealth Management (Palm Desert)'s Nektar Therapeutics position peaked at $9K in Q3 2016.
  • 199 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2016.

Based on Integrated Wealth Management (Palm Desert)'s 13F filing for Q4 2016, filed 6 Jan 2017.